These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9816076)

  • 1. Serum concentrations of hepatocyte growth factor in breast cancer patients.
    Taniguchi T; Toi M; Inada K; Imazawa T; Yamamoto Y; Tominaga T
    Clin Cancer Res; 1995 Sep; 1(9):1031-4. PubMed ID: 9816076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of hepatocyte growth factor in patients with breast cancer.
    Sheen-Chen SM; Liu YW; Eng HL; Chou FF
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):715-7. PubMed ID: 15767355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer.
    Toi M; Taniguchi T; Ueno T; Asano M; Funata N; Sekiguchi K; Iwanari H; Tominaga T
    Clin Cancer Res; 1998 Mar; 4(3):659-64. PubMed ID: 9533534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma.
    Kim CH; Lee JS; Kang SO; Bae JH; Hong SP; Kahng H
    Oral Oncol; 2007 Nov; 43(10):1021-5. PubMed ID: 17306605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma.
    Tanaka K; Miki C; Wakuda R; Kobayashi M; Tonouchi H; Kusunoki M
    Scand J Gastroenterol; 2004 Aug; 39(8):754-60. PubMed ID: 15513361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions.
    Coskun U; Bukan N; Sancak B; Günel N; Ozenirler S; Unal A; Yucel A
    Neoplasma; 2004; 51(3):209-13. PubMed ID: 15254675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor HGF lacks prognostic significance in Mexican breast cancer patients.
    Pruefer FG; Unger-Saldaña K; Mohamier L; Ramírez M; Suárez J; Ramirez MT; Maldonado V; Meléndez-Zajgla J
    J Exp Clin Cancer Res; 2006 Sep; 25(3):357-64. PubMed ID: 17167976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue.
    Beppu K; Uchiyama A; Morisaki T; Nakamura K; Noshiro H; Matsumoto K; Nakamura T; Tanaka M; Katano M
    Anticancer Res; 2000; 20(2B):1263-7. PubMed ID: 10810432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor production by peripheral blood mononuclear cells of recurrent cancer patients.
    Beppu K; Uchiyama A; Morisaki T; Matsumoto K; Nakamura T; Tanaka M; Katano M
    Anticancer Res; 2001; 21(3C):2195-200. PubMed ID: 11501846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
    Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer.
    Yamashita J; Ogawa M; Yamashita S; Nomura K; Kuramoto M; Saishoji T; Shin S
    Cancer Res; 1994 Apr; 54(7):1630-3. PubMed ID: 8137271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of plasma hepatocyte growth factor/scatter factor levels in patients with clinically localized prostate cancer.
    Gupta A; Karakiewicz PI; Roehrborn CG; Lotan Y; Zlotta AR; Shariat SF
    Clin Cancer Res; 2008 Nov; 14(22):7385-90. PubMed ID: 19010854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between anti-tumor effects and serum hepatocyte growth factor level in patients with liver metastases from gastric cancer treated by induced hypertensive chemotherapy with angiotensin II].
    Iwasaki Y; Kitamura M; Arai K
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1874-7. PubMed ID: 9382555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis.
    Junbo H; Li Q; Zaide W; Yunde H
    In Vivo; 1999; 13(2):177-80. PubMed ID: 10363175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma.
    Hu RH; Lee PH; Yu SC; Sheu JC; Lai MY
    Hepatogastroenterology; 1999; 46(27):1842-7. PubMed ID: 10430357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor profile with breast cancer.
    El-Attar HA; Sheta MI
    Indian J Pathol Microbiol; 2011; 54(3):509-13. PubMed ID: 21934211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship and expression of hepatocyte growth factor and vascular endothelial growth factor in serum preoperative and postoperative patients with laryngeal squamous cell cancer].
    Wang Y; Zhao H; Chen J; Liu L; Zhang P; Che J; Wang G
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Dec; 24(24):1112-5. PubMed ID: 21395178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
    Kim CH; Kim J; Kahng H; Choi EC
    Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of serum hepatocyte growth factor, B-cell lymphoma-2 and nitric oxide in primary breast cancer patients.
    Ahmed HH; Metwally FM; Mahdy ES; Shosha WG; Ramadan SS
    Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):958-65. PubMed ID: 22953646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.